About: Clinical prostate cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical prostate cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

journal

Attributes	Values
rdf:type	Item
description	journal (en) czasopismo naukowe (pl) revista científica (es) ساینَسی رِسالہٕ (ks) revue scientifique (fr) rivista scientifica (it) науковий журнал (uk) wissenschaftliche Fachzeitschrift (de) wetenschappelijk tijdschrift (nl)
language of work or name	wds:Q27720792-E3B9F8D4-79A2-4280-B4F3-B3AC0DF3389F
language of work or name	English
OpenCitations bibliographic resource ID	wds:Q27720792-E628F88D-B6EF-4CE1-B871-7F46C16D86AA
Scilit journal ID	wds:Q27720792-6AFCCAC6-B1EB-45AA-BD41-92C132ABE7AB
Crossref journal ID	wds:Q27720792-70B8404C-71A2-4FC0-98BE-390B030DE961
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/1210509
OpenCitations bibliographic resource ID	1210509
Scilit journal ID	2454392
Crossref journal ID	187686
rdfs:label	Clinical prostate cancer (en) Clinical prostate cancer (es) Clinical prostate cancer (nl) Clinical prostate cancer (ast)
skos:prefLabel	Clinical prostate cancer (en) Clinical prostate cancer (es) Clinical prostate cancer (nl) Clinical prostate cancer (ast)
name	Clinical prostate cancer (en) Clinical prostate cancer (es) Clinical prostate cancer (nl) Clinical prostate cancer (ast)
title	wds:Q27720792-F979A89D-BE93-4687-815E-E6B0B65F5794
title	Clinical prostate cancer (en)
NLM Unique ID	wds:Q27720792-4B3FE861-7F77-40B4-87AD-A8667938A198
HAL journal ID	wds:Q27720792-83F61F89-FB11-4549-ADC8-0685CB6099D6
NLM Unique ID	101155459
HAL journal ID	22437
instance of	wds:Q27720792-AA013B0C-8FEC-41C1-BB53-0EEF5D56CC9C
instance of	scientific journal
named after	wds:Q27720792-e234407f-41d8-5b58-5c62-5afdd8d9e92b
named after	prostate cancer
skos:altLabel	Clin Prostate Cancer (en)
OpenAlex ID	wds:Q27720792-BF3EC221-5128-4955-908F-F24222EE3E70
country of origin	wds:Q27720792-46F30785-B89E-4325-9946-E7AF75CDC474
official website	wds:Q27720792-089B567E-C1EA-462D-BE34-1F6DEFCF6F38 wds:Q27720792-47CFE2EF-51A2-4A00-B690-FB6AE8082E20
OpenAlex ID	V2898379015
country of origin	United States of America
official website	http://www.sciencedirect.com/science/journal/15400352 http://ejournals.ebsco.com/direct.asp?JournalID=113120
Scopus source ID	wds:Q27720792-EB727067-3445-4C50-A8C2-95606F61ED7F
ISSN	wds:Q27720792-63FB2BC7-7079-4C8D-929F-349AFAA51332 wds:Q27720792-D0293B34-FD3D-444B-8FE3-85DD980D0F20
ISSN-L	wds:Q27720792-FB7ECEB7-A38D-4F9C-A12E-688F6FC3365E
indexed in bibliographic review	wds:Q27720792-43A01BD5-2541-4BE4-8589-97847B0EC38B
ISSN	urn:ISSN:1540-0352 urn:ISSN:2374-8435
ISSN-L	http://issn.org/resource/ISSN/1540-0352
Scopus source ID	29290
ISSN	1540-0352 2374-8435
ISSN-L	1540-0352
indexed in bibliographic review	Scopus
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q27720792
is published in of	Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia Population screening for prostate cancer and emerging concepts for young men. Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patients Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer Current concepts in the management of erectile dysfunction in men with prostate cancer Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapy Patient preferences in prostate cancer: a clinician's guide to understanding health utilities Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer Activity of epothilone B analogues ixabepilone and patupilone in hormone-refractory prostate cancer. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. The "emigration, migration, and immigration"of prostate cancer Geriatric assessment in elderly patients with prostate cancer Intensity-modulated radiation therapy for prostate cancer Ten-year survival in patients with metastatic prostate cancer The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population Measurement of intracellular versus extracellular prostate-specific antigen levels in peripheral macrophages: a new approach to noninvasive diagnosis of prostate cancer. Does finasteride alter the pathology of the prostate and cancer grading? A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to bone Treating the biochemical recurrence of prostate cancer after definitive primary therapy Active surveillance for prostate cancer with selective delayed definitive therapy An Evaluation of Bicalutamide in the Treatment of Prostate Cancer Thalidomide and analogues: current proposed mechanisms and therapeutic usage Pilot study of a utilities-based treatment decision intervention for prostate cancer patients Screening for prostate cancer A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. Prediction of progression: nomograms of clinical utility Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer The evolving role of estrogen therapy in prostate cancer Phase I/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer. Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software